Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Tips for Starting Your Own Rheumatology Practice

Jason Liebowitz, MD, FACR  |  October 8, 2025

Dr. Anna Zezon discusses the challenges, opportunities & joys of running a private rheumatology practice as a solo practitioner.

Filed under:CareerPractice Support Tagged with:BusinessCareer developmentPractice ManagementPrivate practicesolo practice

Study: Are TNF Inhibitors Safe for Patients with RA-ILD?

Bryn Nelson, PhD  |  October 8, 2025

Despite anecdotal reports to the contrary, a large observational study concludes that TNF inhibitors, compared with non-TNF biological or targeted synthetic DMARDs, do not cause higher rates of death or respiratory hospitalization in patients with RA-ILD.

Filed under:Biologics/DMARDsConditionsDrug UpdatesGuidanceResearch RheumRheumatoid Arthritis Tagged with:Drug Safetyinterstitial lung disease (ILD)lungsRisk FactorsTNF inhibitors

Rheumatologists Applaud Inclusion of Key Medications in Medicare Price Talks

From the College  |  October 5, 2025

In a powerful op-ed published by Fierce Healthcare, rheumatologists Amanda Myers, MD, and Rebecca Shepherd, MD, MBA—both volunteer advocates with the ACR—highlighted the critical role of the Centers for Medicare & Medicaid Services (CMS) in improving access to life-changing medications for patients with autoimmune and rheumatic diseases. Many patients with chronic conditions, such as rheumatoid…

Filed under:Legislation & Advocacy

Oral Treatment for PsA Inches Closer to FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  September 15, 2025

The FDA will consider a supplemental new drug application for deucravacitinib for the treatment of adults with active psoriatic arthritis based on promising results from clinical trials.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:deucravacitinibU.S. Food and Drug Administration (FDA)

A New Treatment for Fibromyalgia?

Michele B. Kaufman, PharmD, BCGP  |  September 11, 2025

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

Filed under:ConditionsDrug UpdatesPain Syndromes Tagged with:Chronic paincyclobenzaprine HCl tabletFDA approvalFibromyalgiaTonmyaU.S. Food and Drug Administration (FDA)

Rheumatology Influencers: Dr. Dave Has a Passion for Giving Back

Linda Childers  |  September 9, 2025

Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community & helping others.

Filed under:CareerLegislation & AdvocacyPractice SupportProfessional TopicsProfilesWorkforce Tagged with:AdvocacyDr. Amish J. Davefellowshiphealth disparitiesLeadershipprior authorizationpublic healthRheumatology InfluencersVolunteerworkforce shortage

Case Reports: Mimics of Polyarteritis Nodosa

Shane Murray, BMBS, RhMSUS, Zhe Ran Duan, MD, PhD, & Daniel DeMizio, MD  |  September 8, 2025

When polyarteritis nodosa isn’t PAN: Two cases of mimics, segmental arterial mediolysis (SAM) & vascular Ehlers-Danlos syndrome (vEDS), are explored.

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumaneurysmscase reportdifferential diagnosisEhlers-Danlosmimicspolyarteritis nodosasegmental arterial mediolysisvasculopathy

AMA State Advocacy Roundtable Addresses Pressing Policy Challenges

From the College  |  September 5, 2025

The roundtable included discussions on emerging issues in state advocacy, prior authorization reform, likely impacts of the Big Beautiful Bill and physician wellness.

Filed under:Legislation & Advocacy Tagged with:AMAstate legislation

Editor's Pick

Celebrating Interdisciplinary Collaboration: Pathways to Success

Teresa J. Brady, PhD, MACR, Basia Belza, PhD, RN, FAAN, FGSA, Kimberly Kimpton, PT, MACR, & Marian T. Hannan, DSc, MPH, MACR  |  September 2, 2025

Four past ARP presidents mark the organization’s 60th anniversary by examining its evolution alongside significant challenges & opportunities in the field.

Filed under:From the CollegePractice SupportWorkforce Tagged with:advanced practice providersAssociation of Rheumatology Professionals (ARP)Collaboration Initiativeshealth professionalsHistoryinterdisciplinaryWorkforce

Sjögren’s Dry Eye Requires Collaboration Among Eye Doctors, Rheumatologists

Vanessa Caceres  |  August 26, 2025

Sjögren’s dry eye requires collaboration between rheumatologists and ophthalmologists for optimal patient management and treatment of this quality-of-life issue.

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumSjögren’s Disease Tagged with:autologous serum tearsCare TeamcollaborationcyclosporineDry eyeEye diseaseHYDROXYCHLOROQUINElifitegrastocularOphthalmologistReferralsicca syndromeSjögren’s Disease supplement

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences